AI CAPITAL INTELLIGENCE
上海宇道生物技术有限公司 · Series C1 · USD 20,000,000–90,000,000 (reported range) · 2026-09-15
Financing facts, at a glance
上海宇道生物技术有限公司: financing disclosed on 2026-09-15, Series C1, USD 20,000,000–90,000,000 (reported range). Named investors: 信宸资本, 德诚资本, 达晨财智, 中生锡创鼎祺基金. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5 · Original source 6
上海宇道生物技术有限公司 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series C1, with an amount of USD 20,000,000–90,000,000 (reported range). Named investors include 信宸资本, 德诚资本, 达晨财智, 中生锡创鼎祺基金.
- Disclosed company name
- 上海宇道生物技术有限公司
- Disclosure date
- 2026-09-15
- Round
- Series C1
- Financing amount
- USD 20,000,000–90,000,000 (reported range)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Enterprise software
Disclosed investors
信宸资本, 德诚资本, 达晨财智, 中生锡创鼎祺基金
Original sources
- Source 1 · news.pedaily.cn
- Source 2 · www.vbdata.cn
- Source 3 · news.pedaily.cn
- Source 4 · bydrug.pharmcube.com
- Source 5 · www.vbdata.cn
- Source 6 · bydrug.pharmcube.com
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.